Brian joined us in 2000. Prior to joining us, he worked in Institutional Sales at Adams Harkness & Canaccord Genuity. Brian has been a Managing Director in Equity Capital Markets since 2008, where he has executed transactions across Growth Sectors. He started his career at The Boston Company. Brian holds a BA in English Language and Literature from The College of the Holy Cross.
Selected Transactions
-
US$16m
Markers Therapeutics
Lead Placement Agent (PIPE)
-
US$92m
Candel Therapeutics
Joint Bookrunner (CMPO)
-
US$75m
Quantum-SI
Sole Agent (At-the-Market Offering)
-
US$18.6m
ASP Isotopes
Sole Bookrunner (Follow-On Offering)
-
US$49m
Arbe Robotics
Sole Bookrunner (Follow-On Offering)
-
US$46m
TELA Bio
Joint Bookrunner (Follow-On Offering)
-
US$27m
Kopin
Sole Bookrunner (Follow-On Offering)
-
US$25m
Arq
Lead Bookrunner (Follow-On Offering)
-
US$420m
Aurora Innovation
Passive Bookrunner (Follow-On Offering)